DIAREX

This brand name is authorized in Ecuador

Active ingredients

The drug DIAREX contains a combination of these active pharmaceutical ingredients (APIs):

1 Nifuroxazide
UNII PM5LI0P38J - NIFUROXAZIDE

Nifuroxazide is a member of benzoic acids. Nifuroxazide is often used as an anti-diarrhoeal medicine.

Read about Nifuroxazide
2 Attapulgite
UNII U6V729APAM - ATTAPULGITE

Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. It physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications.

Read about Attapulgite

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A07BC54 Attapulgite, combinations A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07B Intestinal adsorbents → A07BC Other intestinal adsorbents
Discover more medicines within A07BC54

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria Identifier(s): 04473-MAN-11-06, 5848-MAN-08-10

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.